HomeCompareRPHM vs JEPQ

RPHM vs JEPQ: Dividend Comparison 2026

RPHM yields 10.99% · JEPQ yields 11.10%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 JEPQ wins by $3.5K in total portfolio value
10 years
RPHM
RPHM
● Live price
10.99%
Share price
$18.20
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$41.3K
Annual income
$2,186.89
Full RPHM calculator →
JEPQ
JPMorgan Nasdaq Equity Premium Income ETF
● Live price
11.10%
Share price
$55.52
Annual div
$6.16
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$44.8K
Annual income
$2,152.59
Full JEPQ calculator →

Portfolio growth — RPHM vs JEPQ

📍 JEPQ pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRPHMJEPQ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RPHM + JEPQ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RPHM pays
JEPQ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RPHM
Annual income on $10K today (after 15% tax)
$934.07/yr
After 10yr DRIP, annual income (after tax)
$1,858.86/yr
JEPQ
Annual income on $10K today (after 15% tax)
$943.83/yr
After 10yr DRIP, annual income (after tax)
$1,829.70/yr
At 15% tax rate, RPHM beats the other by $29.15/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RPHM + JEPQ for your $10,000?

RPHM: 50%JEPQ: 50%
100% JEPQ50/50100% RPHM
Portfolio after 10yr
$43.1K
Annual income
$2,169.73/yr
Blended yield
5.04%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on RPHM right now

RPHM
Analyst Ratings
4
Buy
3
Hold
Consensus: Buy
Altman Z
-0.1
Piotroski
3/9
JEPQ
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RPHM buys
0
JEPQ buys
0
No recent congressional trades found for RPHM or JEPQ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRPHMJEPQ
Forward yield10.99%11.10%
Annual dividend / share$2.00$6.16
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$41.3K$44.8K
Annual income after 10y$2,186.89$2,152.59
Total dividends collected$16.4K$16.3K
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: RPHM vs JEPQ ($10,000, DRIP)

YearRPHM PortfolioRPHM Income/yrJEPQ PortfolioJEPQ Income/yrGap
1← crossover$11,799$1,098.90$11,930$1,110.39$131.00JEPQ
2$13,837$1,211.76$14,133$1,224.34$296.00JEPQ
3$16,133$1,328.07$16,632$1,340.46$499.00JEPQ
4$18,710$1,447.20$19,454$1,457.97$744.00JEPQ
5$21,588$1,568.52$22,626$1,576.08$1.0KJEPQ
6$24,791$1,691.42$26,175$1,694.09$1.4KJEPQ
7$28,341$1,815.27$30,133$1,811.32$1.8KJEPQ
8$32,264$1,939.50$34,531$1,927.17$2.3KJEPQ
9$36,587$2,063.54$39,403$2,041.08$2.8KJEPQ
10$41,334$2,186.89$44,787$2,152.59$3.5KJEPQ

RPHM vs JEPQ: Complete Analysis 2026

RPHMStock

Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the development of therapies for patients with rare genetic mitochondrial diseases. It develops REN001, a selective peroxisome proliferator-activated receptor delta agonist, which is in Phase IIb clinical trial in patients with primary mitochondrial myopathies, as well as in Phase 1b clinical trial in patients with long-chain fatty acid oxidation disorders and glycogen storage disease type V. Reneo Pharmaceuticals, Inc. was incorporated in 2014 and is headquartered in San Diego, California.

Full RPHM Calculator →

JEPQETF

The fund seeks to achieve this objective by (1) creating an actively managed portfolio of equity securities comprised significantly of those included in the fund’s primary benchmark, the Nasdaq-100 Index (the Benchmark), and (2) through equity-linked notes (ELNs), selling call options with exposure to the Benchmark. It is non-diversified.

Full JEPQ Calculator →
📬

Get this RPHM vs JEPQ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RPHM vs SCHDRPHM vs JEPIRPHM vs ORPHM vs KORPHM vs MAINRPHM vs XYLDRPHM vs QYLDRPHM vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.